Both are investigated in metabolic research, but Cagrilintide focuses on satiety and feeding behavior, while Retatrutide targets broader metabolic regulation through incretin pathways
[33] broadened the scope to 26 studies ( n = 3,020), including both metabolic RCTs with secondary psychiatric outcomes and a small number of trials in clinical populations (e.g., substance use disorders)
Users who rely solely on the medication for weight reduction risk a condition sometimes referred to as "sarcopenic obesity," where weight is low or normal, but muscle mass is dangerously insufficient
Red ginseng extract primarily reduces physical fatigue by enhancing mitochondrial function in skeletal muscle and increasing ATP production 8
Liposomaal stamt af van het woord liposoom
Phase 2 trial (NEJM 2023) reported 24.2% mean weight loss at 48 weeks with 12 mg/week retatrutide, with gastrointestinal adverse events rising sharply at the 8 mg and 12 mg doses